Literature DB >> 8870629

Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas.

W J Edmunds1, G F Medley, D J Nokes, C J O'Callaghan, H C Whittle, A J Hall.   

Abstract

This paper uses meta-analysis of published data and a deterministic mathematical model of hepatitis B virus (HBV) transmission to describe the patterns of HBV infection in high endemicity areas. We describe the association between the prevalence of carriers and a simple measure of the rate of infection, the age at which half the population have been infected (A50), and assess the contribution of horizontal and perinatal transmission to this association. We found that the two main hyper-endemic areas of sub-Saharan Africa and east Asia have similar prevalences of carriers and values of A50, and that there is a negative nonlinear relationship between A50 and the prevalence of carriers in high endemicity areas (Spearman's Rank, P = 0.0086). We quantified the risk of perinatal transmission and the age-dependent of infection to allow a comparison between the main hyper-endemic areas. East Asia was found to have higher prevalences of HBeAg positive mothers and a greater risk of perinatal transmission from HBeAg positive mothers than sub-Saharan Africa, though the differences were not statistically significant. However, the two areas have similar magnitudes and age-dependent rates of horizontal transmission. Results of a simple compartmental model suggest that similar rates of horizontal transmission are sufficient to generate the similar patterns between A50 and the prevalences of carriers. Interrupting horizontal transmission by mass immunization is expected to have a significant, nonlinear impact on the rate of acquisition of new carriers.

Entities:  

Mesh:

Year:  1996        PMID: 8870629      PMCID: PMC2271713          DOI: 10.1017/s0950268800001497

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  75 in total

1.  Hepatitis B surface antigen in the serum of infants after deliver from asymptomatic carrier mothers.

Authors:  K Okada; T Yamada; Y Miyakawa; M Mayumi
Journal:  J Pediatr       Date:  1975-09       Impact factor: 4.406

2.  Vertical transmission of hepatitis B antigen in Taiwan.

Authors:  C E Stevens; R P Beasley; J Tsui; W C Lee
Journal:  N Engl J Med       Date:  1975-04-10       Impact factor: 91.245

3.  Factors influencing neonatal infection by hepatitis B virus.

Authors:  I L Schweitzer; J W Mosley; M Ashcaval; V M Edwards; L B Overby
Journal:  Gastroenterology       Date:  1973-08       Impact factor: 22.682

4.  Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis.

Authors:  J O Nielsen; O Dietrichson; P Elling; P Christoffersen
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

5.  Hepatitis-associated antigen (HAA) in acute viral hepatitis. Serological and clinical studies.

Authors:  S Iwarson; S Hermodsson
Journal:  Scand J Infect Dis       Date:  1971

6.  Vertical transmission of the hepatitis B surface antigen.

Authors:  I L Schweitzer
Journal:  Am J Med Sci       Date:  1975 Sep-Oct       Impact factor: 2.378

7.  Hepatitis B surface antigen and chronic hepatitis in infants born to asymptomatic carrier mothers.

Authors:  K Shiraki; N Yoshihara; T Kawana; H Yasui; M Sakurai
Journal:  Am J Dis Child       Date:  1977-06

8.  Prevalence of hepatitis B virus infection in the Austral archipelago, French Polynesia: identification of transmission patterns for the formulation of immunization strategies.

Authors:  J P Boutin; F F Sainte Marie; J L Cartel; R Cardines; M Girard; J Roux
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Mar-Apr       Impact factor: 2.184

9.  The e antigen and vertical transmission of hepatitis B surface antigen.

Authors:  R P Beasley; C Trepo; C E Stevens; W Szmuness
Journal:  Am J Epidemiol       Date:  1977-02       Impact factor: 4.897

10.  Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood.

Authors:  F Bortolotti; P Cadrobbi; C Crivellaro; M Guido; M Rugge; F Noventa; R Calzia; G Realdi
Journal:  Gastroenterology       Date:  1990-09       Impact factor: 22.682

View more
  43 in total

1.  Cost-effectiveness analysis of prophylactic lamivudine use in preventing vertical transmission of hepatitis B virus infection.

Authors:  Hui-Fang Hung; Hsiu-Hsi Chen
Journal:  Pharmacoeconomics       Date:  2011-12       Impact factor: 4.981

2.  Acute appendicitis in patients with end-stage renal disease.

Authors:  Pei-Wen Chao; Shuo-Ming Ou; Yung-Tai Chen; Yi-Jung Lee; Feng-Ming Wang; Chia-Jen Liu; Wu-Chang Yang; Tzeng-Ji Chen; Tzen-Wen Chen; Szu-Yuan Li
Journal:  J Gastrointest Surg       Date:  2012-07-10       Impact factor: 3.452

3.  Immunization of babies born to HBsAg positive mothers: An audit on the delivery and completeness of follow up in Norfolk and Suffolk, United Kingdom.

Authors:  Stuart Keeble; Jane Quested; Deborah Barker; Abina Varadarajan; Ananda Giri Shankar
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 4.  Global HBV burden: guesstimates and facts.

Authors:  Dina Ginzberg; Robert J Wong; Robert Gish
Journal:  Hepatol Int       Date:  2018-07-27       Impact factor: 6.047

Review 5.  Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.

Authors:  Ahizechukwu C Eke; George U Eleje; Uzoamaka A Eke; Yun Xia; Jiao Liu
Journal:  Cochrane Database Syst Rev       Date:  2017-02-11

Review 6.  A Review of Human Herpesvirus 8, the Kaposi's Sarcoma-Associated Herpesvirus, in the Pediatric Population.

Authors:  Dorothy E Dow; Coleen K Cunningham; Ann M Buchanan
Journal:  J Pediatric Infect Dis Soc       Date:  2013-09-04       Impact factor: 3.164

7.  Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B.

Authors:  Adrian M Di Bisceglie; Wendy C King; Mauricio Lisker-Melman; Mandana Khalili; Steven H Belle; Jordan J Feld; Marc G Ghany; Harry L A Janssen; Daryl Lau; William M Lee; Simon C Ling; Stewart Cooper; Philip Rosenthal; Kathleen B Schwarz; Richard K Sterling; Jeffrey H Teckman; Norah Terrault
Journal:  J Viral Hepat       Date:  2019-05-02       Impact factor: 3.728

8.  Economic evaluation on infant hepatitis B vaccination combined with immunoglobulin in China, 2013.

Authors:  Yuan-Sheng Chen; Hui Zheng; Yan-Min Liu; Fu-Zhen Wang; Zhen-Hua Wu; Ning Miao; Xiao-Jin Sun; Guo-Min Zhang; Fu-Qiang Cui; Xiao-Feng Liang
Journal:  Hum Vaccin Immunother       Date:  2016-02-18       Impact factor: 3.452

9.  Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants.

Authors:  Charles S Chasela; Athena P Kourtis; Patrick Wall; Jan Drobeniuc; Caroline C King; Hong Thai; Eyasu H Teshale; Mina Hosseinipour; Sascha Ellington; Mary B Codd; Denise J Jamieson; Rod Knight; Patricia Fitzpatrick; Saleem Kamili; Irving Hoffman; Dumbani Kayira; Noel Mumba; Deborah D Kamwendo; Francis Martinson; William Powderly; Chong-Gee Teo; Charles van der Horst
Journal:  J Hepatol       Date:  2013-11-06       Impact factor: 25.083

10.  Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment.

Authors:  Solomon Chih-Cheng Chen; Mehlika Toy; Jennifer M Yeh; Jung-Der Wang; Stephen Resch
Journal:  Pediatrics       Date:  2013-03-25       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.